![](https://investorshub.advfn.com/uicon/78991.png?cb=1630499252)
Thursday, February 15, 2018 10:14:35 AM
Pending prurisol data. Topline data could be posted any day now.
December 21, 2017
Innovation Pharmaceuticals Completes Final Patient Visit in Phase 2b Study of Oral Prurisol for Psoriasis
https://www.ipharminc.com/press-release/2017/12/21/innovation-pharmaceuticals-completes-final-patient-visit-in-phase-2b-study-of-oral-prurisol-for-psoriasis
Pending brilacidin partnership while moving forward through CDA's to meet with the FDA for phase 3 formats.
The Company is now working to complete the Clinical Study Report (CSR). The CSR is central for engaging with the FDA to further discuss program development, and is also an important component for informing already advanced OM partnership discussions. In Brilacidin-OM, based on the strong positive Phase 2 clinical results, the Company believes it has a highly promising and unique late-stage OM drug candidate that, with approval, could assume the leadership position in a market with untapped economic potential. The global OM market is expected to exceed $1 billion in the next few years.
https://www.ipharminc.com/press-release/2018/1/3/innovation-pharmaceuticals-brilacidin-meets-key-secondary-endpoint-in-phase-2-trial-delays-onset-of-severe-oral-mucositis-som
Pending expanded access use for both prurisol and brilacidin my words on this one, prior to phase 3 kickoff for both imo.
https://www.ipharminc.com/expanded-access-and-compassionate-use/
Pending oral pill formulation and trial for kevetrin.
Pending lift off.
Check out the sticky posts.
Volume today (and lately) speaks for itself. Small accumulation soaking up whatever we can.
Anticipation.
Personally, I do continue to accumulate. News that changes the whole landscape for Innovation Pharmaceuticals Inc. ($IPIX) can come at any moment. Stick with your own due diligence and stay away from message boards if you must. If the science is right, this will make for quite the payday.
IPIX Milestones, Clinical Trials, Recent Articles, Corporate Overview, Patents
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138444424
OUTSTANDING POTENTIAL FOR Innovation Pharmaceuticals Inc.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138424113
For B-OM, 5-10M upfront 20-40M if approved and
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138082418
IPIX Clinical Trial Timelines
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=135407422
Kevetrin's successful trial and moving forward with oral formulation...
https://www.ipharminc.com/press-release/2018/2/8/innovation-pharmaceuticals-concludes-successful-phase-2a-trial-of-kevetrin-for-ovarian-cancer-intra-tumor-modulation-of-p53-observed
All IMHO. Just about ready to rock and roll.
$IPIX
"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM